ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

LUIS ALONZO M.D.

610 E GRANT AVE IROQUOIS CENTER FOR HUMAN DEVELOPMENT, INC.

Greensburg | Kansas | 67054

(620) 723-2272

Incorrect Info?
Search this name in Dollars for Docs »
See this provider's services »

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,851Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 127

$1.44M Total Retail Price of All Prescriptions

Rank: 4 out of 127

598 Patients Receiving at Least One Drug in Part D
51%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 598 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 3,523 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$162 was the average price of a prescription from this provider, compared to $141 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
MIRTAZAPINE 515 329 1 12
SEROQUEL XR 428 242 2 19
CYMBALTA 376 139 3 6
RISPERIDONE 320 121 4 2
BUPROPION XL 310 113 5 16
SERTRALINE HCL 306 137 6 5
TOPIRAMATE 259 65 7 28
DIVALPROEX SODIUM ER 254 43 8 14
TRAZODONE HCL 241 87 9 1
BENZTROPINE MESYLATE 235 34 R 10 10
ABILIFY 234 82 11 4
OLANZAPINE 233 106 12 13
CITALOPRAM HBR 219 127 13 3
QUETIAPINE FUMARATE 200 57 14 7
NAMENDA 189 179 15 34
DIVALPROEX SODIUM 178 62 16 23
FLUVOXAMINE MALEATE 172 78 17 52
INVEGA 169 34 18 33
LAMOTRIGINE 169 30 18 8
EXELON 156 151 20 53
CLOZAPINE 140 29 21 17
ZIPRASIDONE HCL 140 29 21 21
DONEPEZIL HCL 134 118 23 35
RISPERDAL CONSTA 123 0 24 27
GABAPENTIN 121 72 25 25
OLANZAPINE ODT 121 38 25 56
VENLAFAXINE HCL ER 119 47 27 15
ESCITALOPRAM OXALATE 109 47 28 18
PRISTIQ ER 103 29 29 30
ZOLPIDEM TARTRATE 102 18 30 9
LITHIUM CARBONATE 94 12 31 22
LEVOTHYROXINE SODIUM 92 27 32 40
INVEGA SUSTENNA 91 0 33 32
LATUDA 90 11 34 42
SEROQUEL 80 18 35 24
PAROXETINE HCL 75 28 36 26
FLUOXETINE HCL 70 13 37 11
VIIBRYD 65 19 38 59
METHYLPHENIDATE HCL 61 20 39 49
HYDROXYZINE HCL 59 0 R 40 57
METFORMIN HCL 53 15 41 69
NEXIUM 53 36 41 87
AMITRIPTYLINE HCL 51 11 R 43 65
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.